Terms: = Kidney tumors AND TBX3, TBX3-ISO, ENSG00000135111, 6926, O15119, XHL, UMS
2 results:
1. Leveraging diverse cell-death related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma.
Wu Z; Jin M; Xin P; Zhang H
Front Immunol; 2023; 14():1293729. PubMed ID: 38146369
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and Safety of the 64Cu(II)Cl2 PET/CT for Urological Malignancies: Phase IIa Clinical Study.
Mascia M; Villano C; De Francesco V; Schips L; Marchioni M; Cindolo L
Clin Nucl Med; 2021 Jun; 46(6):443-448. PubMed ID: 33883484
[TBL] [Abstract] [Full Text] [Related]
